Tuberc Respir Dis.
2009 Jun;66(6):477-481.
A Case of Interstitial Pneumonitis in a Patient with Rheumatoid Arthritis Treated with Leflunomide
- Affiliations
-
- 1Division of Rheumatology, Department of Internal Medicine, Daejeon St. Mary's Hospital, The Catholic University of Korea, Daejeon, Korea. kohj8804@catholic.ac.kr
- 2Division of Pulmonology, Department of Internal Medicine, Daejeon St. Mary's Hospital, The Catholic University of Korea, Daejeon, Korea.
Abstract
- Leflunomide, a disease-modifying antirheumatic drug (DMARD) for the treatment of rheumatoid arthritis has been available in Korea since 2003. Leflunomide-associated interstitial pneumonitis has been appearing recently. A 25-year-old woman with a 12-month history of seronegative rheumatoid arthritis (RA) presented with acute respiratory insufficiency. She developed fever, dyspnea, and non-productive cough. Her medication history included methotrexate (15 mg/week. commencing 1 year prior) and leflunomide (20 mg/day, no loading dose, commencing 4 months prior). She was diagnosed with leflunomide-associated interstitial pneumonitis based on history, physical examination, laboratory and radiologic findings. She recovered quickly after leflunomide was withdrawn and steroids and cholestyramine were initiated quickly. We report a case of leflunomide-associated interstitial pneumonitis treated successfully with intravenous high-dose steroid and cholestyramine.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Successful Treatment of Interstitial Pneumonitis Induced by Leflunomide
- A Case of Interstitial Pneumonitis Caused by Leflunomide
- A Case of Peripheral Neuropathy in a Patient with Rheumatoid Arthritis Treated with Leflunomide
- Leflunomide-induced Toxic Epidermal Necrolysis in a Patient with Rheumatoid Arthritis
- A Case of Methotrexate: Associated Interstitial Pneumonitis in Rheumatoid Arthritis
